Ethical Considerations and Data Analysis in COVID-19 Vaccine Clinical Trials

The chapter discusses the ethical considerations of vaccinating the placebo group in COVID-19 vaccine trials, emphasizing the importance of avoiding bias. It analyzes data from Pfizer clinical trial reports to compare all-cause mortality between vaccinated and placebo groups and highlights the FDA's reluctance to release related information.